Veterinary Virology and Animal Viral Diseases, Department of Infectious and Parasitic Diseases, FARAH Research Centre, Faculty of Veterinary Medicine, Liège University, Liège, Belgium.
Present address: The Babraham Institute, Babraham Hall House, Babraham, Cambridge, UK.
J Gen Virol. 2020 May;101(5):510-522. doi: 10.1099/jgv.0.001406. Epub 2020 Apr 3.
Noroviruses are recognized as the major cause of non-bacterial gastroenteritis in humans. Molecular mechanisms driving norovirus evolution are the accumulation of point mutations and recombination. Recombination can create considerable changes in a viral genome, potentially eliciting a fitness cost, which must be compensated via the adaptive capacity of a recombinant virus. We previously described replicative fitness reduction of the first generated WU20-CW1 recombinant murine norovirus, RecMNV. In this follow-up study, RecMNV's capability of replicative fitness recuperation and genetic characteristics of RecMNV progenies at early and late stages of an adaptation experiment were evaluated. Replicative fitness regain of the recombinant was demonstrated via growth kinetics and plaque size differences between viral progenies prior to and post serial passaging. Point mutations at consensus and sub-consensus population levels of early and late viral progenies were characterized via next-generation sequencing and putatively associated to fitness changes. To investigate the effect of genomic changes separately and in combination in the context of a lab-generated inter-MNV infectious virus, mutations were introduced into a recombinant WU20-CW1 cDNA for subsequent DNA-based reverse genetics recovery. We thus associated fitness loss of RecMNV to a C7245T mutation and functional VP2 (ORF3) truncation and demonstrated individual and cumulative compensatory effects of one synonymous OFR2 and two non-synonymous ORF1 consensus-level mutations acquired during successive rounds of replication. Our data provide evidence of viral adaptation in a controlled environment via genetic drift after genetic shift induced a fitness cost of an infectious recombinant norovirus.
诺如病毒被认为是人类非细菌性肠胃炎的主要病原体。驱动诺如病毒进化的分子机制是点突变的积累和重组。重组可以使病毒基因组发生相当大的变化,可能会产生适应性成本,这必须通过重组病毒的适应能力来补偿。我们之前描述了首例产生的 WU20-CW1 重组鼠诺如病毒 RecMNV 的复制适应性降低。在这项后续研究中,评估了 RecMNV 在适应性实验早期和晚期复制适应性恢复能力和 RecMNV 后代的遗传特征。通过病毒后代在连续传代前后生长动力学和蚀斑大小差异,证明了重组体的复制适应性恢复。通过下一代测序对早期和晚期病毒后代的共识和亚共识群体水平的点突变进行了特征描述,并推测与适应性变化有关。为了在实验室产生的 inter-MNV 传染性病毒的背景下分别和组合地研究基因组变化的影响,将突变引入重组 WU20-CW1 cDNA 中,以便随后进行基于 DNA 的反向遗传学恢复。因此,我们将 RecMNV 的适应性降低归因于 C7245T 突变和功能性 VP2(ORF3)截断,并证明了在连续复制轮次中获得的一个同义 ORF2 和两个非同义 ORF1 共识水平突变的单独和累积补偿效应。我们的数据提供了在受控环境中通过遗传漂移进行病毒适应的证据,因为遗传转移导致传染性重组诺如病毒的适应性成本。